Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer. It focuses on the utilization of oncolytic viruses through an allogeneic cell-based delivery system. The system helps to overcome the host immune defense mechanisms, amplify the oncolytic viruses, and modify the tumor microenvironment.